{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:25Z","timestamp":1786112785778,"version":"build-2736575974"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Metabolic-associated fatty liver disease (MAFLD) affects approximately 30% of the global population and is associated with obesity and metabolic syndrome. Anthropometric indices such as body mass index (BMI), waist circumference (WC), and weight are crucial markers for evaluating the progression of MAFLD. Curcumin, a bioactive compound with anti-inflammatory and antioxidant properties, has been investigated for its potential to improve metabolic outcomes. This umbrella review aimed to systematically evaluate the effects of curcumin supplementation on anthropometric indices in patients with MAFLD, considering epidemiological strength and power analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      An umbrella review of meta-analyses from randomized controlled trials was conducted. PubMed, Scopus, and Web of Science were searched up to September 2024. Meta-analyses assessing curcumin\u2019s effects on BMI, weight, and WC in MAFLD patients were included. Quality was assessed using the A Measurement Tool to Assess Systematic Reviews version (AMSTAR-2) tool, and heterogeneity was evaluated using the I\n                      <jats:sup>2<\/jats:sup>\n                      statistic. Statistical analyses were performed using R and Stata 18 software.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Curcumin supplementation had no significant effect on BMI (standardized mean difference [SMD]: \u22120.01; 95% confidence interval [CI]: \u22120.24 to 0.21,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.91) with low power (1-\u03b2\u2005=\u20050.03) and a low epidemiological grade according to GRADE criteria. Similarly, curcumin showed no significant effect on WC (SMD: \u22120.27; 95% CI: \u22120.57 to 0.04,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.08) with high power (1-\u03b2\u2005=\u20050.96) but low epidemiological strength. However, curcumin significantly reduced weight (SMD: \u22120.12; 95% CI: \u22120.19 to \u22120.04,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.01) with moderate power (1-\u03b2\u2005=\u20050.56) and moderate epidemiological strength. No significant effect of dose or effect of supplementation duration was found.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Curcumin supplementation may result in a statistically detectable but clinically modest reduction in body weight in patients with MAFLD, while showing limited or no efficacy on BMI and waist circumference. The epidemiological strength of the evidence varies across outcomes and is of low to moderate quality. Further well-designed, high-quality randomized controlled trials are needed to confirm the clinical relevance of curcumin\u2019s effects on anthropometric indices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048629","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:01:42Z","timestamp":1778745702000},"page":"e48629","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effects of curcumin on anthropometric measurements in nonalcoholic fatty liver disease: An umbrella meta-analysis study"],"prefix":"10.1097","volume":"105","author":[{"given":"Abinash","family":"Mahapatro","sequence":"first","affiliation":[{"name":"SIU School of Medicine, Springfield, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herby","family":"Jeanty","sequence":"additional","affiliation":[{"name":"The Brooklyn Hospital Center, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saisree Reddy","family":"Adla Jala","sequence":"additional","affiliation":[{"name":"Mission Hospital, Asheville, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavya","family":"Priya Somu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Centinela Hospital Medical Center, Inglewood, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Madineni","sequence":"additional","affiliation":[{"name":"Florida State University, Tallahassee, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elan","family":"Mohanty","sequence":"additional","affiliation":[{"name":"Mary Medical Center Apple Valley, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Dheyaa","family":"Marsool","sequence":"additional","affiliation":[{"name":"Research Fellow, Mayo Clinic, Scottsdale, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pourya","family":"Shamsi","sequence":"additional","affiliation":[{"name":"Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shahriari Namin","sequence":"additional","affiliation":[{"name":"Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Abbaszadeh","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parsa","family":"Saberian","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Amini-Salehi","sequence":"additional","affiliation":[{"name":"Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-3359","authenticated-orcid":false,"given":"Arezoo","family":"Ghazalgoo","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","article-title":"Global prevalence of nonalcoholic fatty liver disease: an updated review meta-analysis comprising a population of 78 million from 38 countries.","volume":"55","author":"Amini-Salehi","year":"2024","journal-title":"Arch Med Res"},{"key":"R2-20260805","first-page":"1600","article-title":"The prevalence of non-alcoholic fatty liver disease in Iranian Children and adult population: a systematic review and meta-analysis.","volume":"52","author":"Hassanipour","year":"2023","journal-title":"Iran J Public Health"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"e131523","DOI":"10.5812\/hepatmon-131523","article-title":"Risk factors of non-alcoholic fatty liver disease in the Iranian adult population: a systematic review and meta-analysis.","volume":"23","author":"Amini-Salehi","year":"2023","journal-title":"Hepat Mon"},{"key":"R4-20260805","first-page":"35","article-title":"Nonalcoholic fatty liver disease: diagnosis and management.","volume":"88","author":"Wilkins","year":"2013","journal-title":"Am Fam Physician"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"77","DOI":"10.21037\/hbsn.2018.11.06","article-title":"Non-alcoholic fatty liver disease (NAFLD) and the quest for effective treatments.","volume":"8","author":"Thanapirom","year":"2019","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges.","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7570\/jomes22021","article-title":"Recent epidemiology and risk factors of nonalcoholic fatty liver disease.","volume":"31","author":"Huh","year":"2022","journal-title":"J Obes Metab Syndr"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies.","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"103110","DOI":"10.1016\/j.dsx.2024.103110","article-title":"Gut microbiota interventions in type 2 diabetes mellitus: an umbrella review of glycemic indices.","volume":"18","author":"Keivanlou","year":"2024","journal-title":"Diabetes Metab Syndr"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/nutrit\/nuad086","article-title":"The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis.","volume":"82","author":"Amini-Salehi","year":"2024","journal-title":"Nutr Rev"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.numecd.2024.05.017","article-title":"Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: an umbrella review.","volume":"34","author":"Amini-Salehi","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41387-024-00281-7","article-title":"The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review.","volume":"14","author":"Vakilpour","year":"2024","journal-title":"Nutr Diabetes"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1097\/MS9.0000000000001740","article-title":"Can modulation of gut microbiota affect anthropometric indices in patients with non-alcoholic fatty liver disease? An umbrella meta-analysis of randomized controlled trials.","volume":"86","author":"Amini-Salehi","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clnesp.2023.07.087","article-title":"Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: an umbrella study on meta-analyses.","volume":"57","author":"Mahapatro","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13643-023-02299-x","article-title":"Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study.","volume":"12","author":"Naghipour","year":"2023","journal-title":"Syst Rev"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"e02","DOI":"10.15420\/ecr.2023.19","article-title":"Management of cardiovascular risk in the non-alcoholic fatty liver disease setting.","volume":"19","author":"Linero","year":"2024","journal-title":"Eur Cardiol"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review.","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/jcm10030467","article-title":"NAFLD and Cardiovascular diseases: epidemiological, mechanistic and therapeutic considerations.","volume":"10","author":"Niederseer","year":"2021","journal-title":"J Clin Med"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jceh.2017.05.005","article-title":"Simple anthropometric indices are useful for predicting non-alcoholic fatty liver disease [NAFLD] in Asian Indians.","volume":"7","author":"Singh","year":"2017","journal-title":"J Clin Exp Hepatol"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"194","DOI":"10.25122\/jml-2018-0031","article-title":"The role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS).","volume":"11","author":"Mansour-Ghanaei","year":"2018","journal-title":"J Med Life"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12876-018-0840-9","article-title":"Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults.","volume":"18","author":"K\u00fchn","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12944-021-01568-9","article-title":"Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.","volume":"20","author":"Cai","year":"2021","journal-title":"Lipids Health Dis"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"362147","DOI":"10.1155\/2012\/362147","article-title":"Role of body mass index, waist-to-height and waist-to-hip ratio in prediction of nonalcoholic fatty liver disease.","volume":"2012","author":"Zheng","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art.","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s43161-023-00164-5","article-title":"\u201cAnthropometric measurements and exercise interventions in non-alcoholic fatty liver disease patients\u201d: a literature review.","volume":"29","author":"Sedhunivas","year":"2024","journal-title":"Bull Faculty Physical Ther"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"1040259","DOI":"10.3389\/fnut.2022.1040259","article-title":"Impacts of turmeric and its principal bioactive curcumin on human health: pharmaceutical, medicinal, and food applications: a comprehensive review.","volume":"9","author":"El-Saadony","year":"2022","journal-title":"Front Nutr"},{"key":"R27-20260805","doi-asserted-by":"crossref","first-page":"1216708","DOI":"10.3389\/fendo.2023.1216708","article-title":"Effects of dietary polyphenol curcumin supplementation on metabolic, inflammatory, and oxidative stress indices in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.","volume":"14","author":"Qiu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.3390\/ijms241814366","article-title":"Therapeutic effects of curcumin derivatives against obesity and associated metabolic complications: a review of in vitro and in vivo studies.","volume":"24","author":"Moetlediwa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fphar.2019.00649","article-title":"The effects of curcumin on weight loss among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.","volume":"10","author":"Akbari","year":"2019","journal-title":"Front Pharmacol"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ajcnut.2023.03.006","article-title":"The effect of curcumin supplementation on weight loss and anthropometric indices: an umbrella review and updated meta-analyses of randomized controlled trials.","volume":"117","author":"Unhapipatpong","year":"2023","journal-title":"Am J Clin Nutr"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"102843","DOI":"10.1016\/j.ctim.2022.102843","article-title":"Curcumin as adjuvant treatment in patients with non-alcoholic fatty liver (NAFLD) disease: A systematic review and meta-analysis.","volume":"68","author":"Ngu","year":"2022","journal-title":"Complement Ther Med"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"102283","DOI":"10.1016\/j.ctim.2019.102283","article-title":"The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.","volume":"48","author":"Jalali","year":"2020","journal-title":"Complement Ther Med"},{"key":"R33-20260805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nutrit\/nuad166","article-title":"Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.","volume":"83","author":"Vajdi","year":"2024","journal-title":"Nutr Rev"},{"key":"R34-20260805","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.imr.2018.07.004","article-title":"Efficacy of curcumin\/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: a systematic review of randomized controlled trials.","volume":"8","author":"Mansour-Ghanaei","year":"2019","journal-title":"Integr Med Res"},{"key":"R36-20260805","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R37-20260805","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R38-20260805","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ptr.6542","article-title":"The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: a systematic review and dose-response meta-analysis of randomized controlled trials.","volume":"34","author":"Baziar","year":"2020","journal-title":"Phytother Res"},{"key":"R39-20260805","doi-asserted-by":"crossref","first-page":"103025","DOI":"10.1016\/j.ctim.2024.103025","article-title":"Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: a systematic review and meta-analysis of randomized clinical trials.","volume":"80","author":"Ebrahimzadeh","year":"2024","journal-title":"Complement Ther Med"},{"key":"R40-20260805","doi-asserted-by":"crossref","first-page":"949746","DOI":"10.3389\/fimmu.2022.949746","article-title":"Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"key":"R41-20260805","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3138\/canlivj-2023-0022","article-title":"Effects of curcumin in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.","volume":"7","author":"Malik","year":"2024","journal-title":"Can Liver J"},{"key":"R42-20260805","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.3390\/ijerph20054266","article-title":"Meta-analysis of exploring the effect of curcumin supplementation with or without other advice on biochemical and anthropometric parameters in patients with metabolic-associated fatty liver disease (MAFLD).","volume":"20","author":"R\u00f3\u017ca\u0144ski","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"R43-20260805","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12072-018-9910-x","article-title":"The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.","volume":"13","author":"Wei","year":"2019","journal-title":"Hepatol Int"},{"key":"R44-20260805","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/acsptsci.2c00012","article-title":"Role of turmeric and curcumin in prevention and treatment of chronic diseases: lessons learned from clinical trials.","volume":"6","author":"Kunnumakkara","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"R45-20260805","doi-asserted-by":"crossref","first-page":"1163950","DOI":"10.3389\/fnut.2023.1163950","article-title":"The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers.","volume":"10","author":"Safari","year":"2023","journal-title":"Front Nutr"},{"key":"R46-20260805","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/foods6100092","article-title":"Curcumin: a review of its effects on human health.","volume":"6","author":"Hewlings","year":"2017","journal-title":"Foods"},{"key":"R47-20260805","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2478\/jtim-2019-0023","article-title":"Effect of weight reduction on histological activity and fibrosis of lean nonalcoholic steatohepatitis patient.","volume":"7","author":"Alam","year":"2019","journal-title":"J Transl Int Med"},{"key":"R48-20260805","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/ijerph21060708","article-title":"The long-term effect of weight loss on the prevention of progression to cirrhosis among patients with obesity and MASH-related F3 liver fibrosis.","volume":"21","author":"Niu","year":"2024","journal-title":"Int J Environ Res Public Health"},{"key":"R49-20260805","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/ijerph21060757","article-title":"Advantages and limitations of the body mass index (BMI) to assess adult obesity.","volume":"21","author":"Wu","year":"2024","journal-title":"Int J Environ Res Public Health"},{"key":"R50-20260805","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7762\/cnr.2019.8.3.196","article-title":"Does Turmeric\/curcumin supplementation change anthropometric indices in patients with non-alcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.","volume":"8","author":"Jafarirad","year":"2019","journal-title":"Clin Nutr Res"},{"key":"R51-20260805","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/10408398.2018.1517724","article-title":"The effects of curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials.","volume":"60","author":"Mousavi","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R52-20260805","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/nu13061977","article-title":"Beyond the paradigm of weight loss in non-alcoholic fatty liver disease: from pathophysiology to novel dietary approaches.","volume":"13","author":"Armandi","year":"2021","journal-title":"Nutrients"},{"key":"R53-20260805","doi-asserted-by":"crossref","first-page":"663351","DOI":"10.3389\/fendo.2021.663351","article-title":"Efficacy of weight reduction on pediatric nonalcoholic fatty liver disease: opportunities to improve treatment outcomes through pharmacotherapy.","volume":"12","author":"Friesen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R54-20260805","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.2147\/DDDT.S518547","article-title":"Role of curcumin in chronic liver diseases: a comprehensive review.","volume":"19","author":"Sun","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"R55-20260805","doi-asserted-by":"crossref","first-page":"1603018","DOI":"10.3389\/fimmu.2025.1603018","article-title":"Curcumin, an active component of turmeric: biological activities, nutritional aspects, immunological, bioavailability, and human health benefits - a comprehensive review.","volume":"16","author":"El-Saadony","year":"2025","journal-title":"Front Immunol"},{"key":"R56-20260805","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/bcr724","article-title":"Are herbal remedies and dietary supplements safe and effective for breast cancer patients?","volume":"5","author":"Cassidy","year":"2003","journal-title":"Breast Cancer Res"},{"key":"R57-20260805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cnur.2020.10.001","article-title":"Herbal supplements: precautions and safe use.","volume":"56","author":"Williams","year":"2021","journal-title":"Nurs Clin North Am"},{"key":"R58-20260805","first-page":"55","article-title":"Turmeric-induced Liver Injury.","volume":"14","author":"Alghzawi","year":"2024","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"R59-20260805","first-page":"6029403","article-title":"Drug induced liver injury attributed to a curcumin supplement.","volume":"2019","author":"Imam","year":"2019","journal-title":"Case Rep Gastrointest Med"},{"key":"R60-20260805","doi-asserted-by":"crossref","first-page":"9286","DOI":"10.3390\/ijms26199286","article-title":"Curcumin attenuates liver steatosis via antioxidant and anti-inflammatory pathways in obese patients with type 2 diabetes mellitus: a randomized controlled trial.","volume":"26","author":"Yaikwawong","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R61-20260805","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1007\/s12011-024-04314-1","article-title":"Curcumin treatment ameliorates hepatic insulin resistance induced by sub-chronic oral exposure to cadmium LOAEL dose via NF-\u03baB and Nrf2 pathways.","volume":"203","author":"Sarmiento-Ortega","year":"2025","journal-title":"Biol Trace Elem Res"},{"key":"R62-20260805","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/foods15010060","article-title":"Clinical potential of Curcuma longa Linn. as nutraceutical\/dietary supplement for metabolic syndrome: systematic review and meta-analysis of randomized controlled trials.","volume":"15","author":"Kehinde","year":"2025","journal-title":"Foods"},{"key":"R63-20260805","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3390\/nu17121972","article-title":"Curcumin for inflammation control in individuals with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial.","volume":"17","author":"Yaikwawong","year":"2025","journal-title":"Nutrients"},{"key":"R64-20260805","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.3390\/nu16234177","article-title":"Curcumin attenuates hyperglycemia and inflammation in type 2 diabetes mellitus: quantitative analysis of randomized controlled trial.","volume":"16","author":"Mokgalaboni","year":"2024","journal-title":"Nutrients"},{"key":"R65-20260805","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41387-025-00386-7","article-title":"The effect of turmeric\/curcumin supplementation on anthropometric indices in subjects with prediabetes and type 2 diabetes mellitus: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.","volume":"15","author":"Moradi Baniasadi","year":"2025","journal-title":"Nutr Diabetes"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:01:04Z","timestamp":1785945664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":64,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048629","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2024-12-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}